APA

Park S., Zhao H., Jang Y., Mueller R. A. & Xu Z. (20060814). N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. : The Journal of pharmacology and experimental therapeutics.

Chicago

Park Sung-Sik, Zhao Hong, Jang Yeongho, Mueller Robert A and Xu Zhelong. 20060814. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. : The Journal of pharmacology and experimental therapeutics.

Harvard

Park S., Zhao H., Jang Y., Mueller R. A. and Xu Z. (20060814). N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. : The Journal of pharmacology and experimental therapeutics.

MLA

Park Sung-Sik, Zhao Hong, Jang Yeongho, Mueller Robert A and Xu Zhelong. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. : The Journal of pharmacology and experimental therapeutics. 20060814.